| Banner Sun Health Research Institute | |
|---|---|
| Logo placeholder | |
| Location | Sun City, Arizona, USA |
| Type | Research Institute |
| Website | https://www.bannerhealth.com/research/ |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, Brain Donation, Biomarker Development |
| Founded | 1986 |
Banner Sun Health Research Institute (BSHRI), located in Sun City, Arizona, is one of the nation's leading research centers for Alzheimer's disease, Parkinson's disease, and related neurodegenerative disorders. Founded in 1986, the institute is particularly renowned for its brain donation program, which has provided invaluable tissue for researchers worldwide[1]. With over 35 years of service to the neuroscience community, Banner Sun Health has established itself as a critical resource for advancing understanding of neurodegenerative disease mechanisms.
The institute's location in the retirement community of Sun City, Arizona, provides unique access to a large population of elderly individuals who have volunteered as brain donors, facilitating longitudinal research on aging and neurodegenerative diseases. This demographic advantage, combined with the institute's rigorous neuropathological protocols, has made Banner Sun Health one of the most valuable resources for the global neuroscience research community[2].
Banner Sun Health is part of Banner Research, which also includes the Banner Alzheimer's Institute and multiple other research programs across the Banner Health system. The institute maintains active clinical trials programs and continues to expand its research portfolio in biomarker development and therapeutic targets[3].
Banner Sun Health Research Institute was founded in 1986 as the Sun Health Research Institute, with a original focus on understanding the aging brain and neurodegenerative diseases that affect the aging population. The founding vision was to create a research center that could leverage the unique demographic advantages of the Sun City retirement community to advance understanding of age-related neurological conditions.
The institute's brain donation program was established in the early 1990s, responding to a critical need in the research community for well-characterized brain tissue from individuals with documented clinical histories. Unlike many brain banks that receive tissue from medical examiners without detailed clinical information, Banner Sun Health's program recruits participants during life, enabling comprehensive longitudinal clinical characterization.
Over the past three decades, the institute has grown to become one of the nation's leading centers for Alzheimer's disease and Parkinson's disease research[2:1]. Key milestones include:
The institute became part of Banner Health, one of the largest non-profit health systems in the United States, providing additional resources and integration with clinical care networks. This integration has facilitated the expansion of clinical research programs and enabled more efficient translation of research findings into patient care.
The Banner Sun Health Brain Bank is one of the world's largest and most well-characterized brain donation programs for neurodegenerative diseases[2:2]. The program has collected tissue from over 4,000 donors, making it an invaluable resource for the global neuroscience community.
Participant Recruitment and Characterization: Unlike many brain banks, Banner Sun Health recruits participants during life, enabling comprehensive clinical characterization. Participants undergo detailed neurological examinations, cognitive assessments, and medical history documentation. This approach ensures that researchers receive not only high-quality tissue but also detailed clinical information about the donor.
Rapid Autopsy Protocol: The institute maintains a rapid autopsy program that ensures optimal tissue preservation. The goal is to obtain brain tissue within hours of death, preserving cellular morphology and molecular integrity. This rapid processing is critical for molecular studies, including gene expression analysis and protein quantification.
Neuropathological Evaluation: All brains undergo comprehensive neuropathological evaluation by experienced neuropathologists. Standard assessments include:
Tissue Distribution: The brain bank distributes tissue to researchers worldwide, supporting studies ranging from basic science investigations to clinical translation research. Tissue requests are reviewed by a scientific advisory committee to ensure appropriate use.
The Banner Sun Health Brain Bank has enabled numerous landmark discoveries in neurodegenerative disease research:
Banner Sun Health conducts comprehensive Alzheimer's disease research across multiple domains[4]:
Brain Banking and Neuropathology: The cornerstone of the AD research program, providing well-characterized brain tissue for studies on disease mechanisms, biomarker validation, and therapeutic target identification.
Biomarker Studies: Identification and validation of fluid biomarkers (CSF and blood) and imaging markers for early detection of Alzheimer's disease. The institute has contributed to validation of amyloid-beta, tau, and neurofilament light chain (NfL) biomarkers[5].
Genetic Studies: Understanding genetic risk factors and protective factors for Alzheimer's disease through analysis of donor DNA and correlation with neuropathological findings.
Clinical Studies: Observational studies tracking disease progression and clinical trials of novel therapeutic agents[3:1].
The institute has robust Parkinson's disease research programs[6]:
Lewy Body Studies: Detailed pathological studies characterizing alpha-synuclein pathology in Parkinson's disease and related disorders[7]. Research has focused on:
Brain Bank Resources: Providing high-quality tissue for PD research worldwide, supporting studies on disease mechanisms and therapeutic development.
Clinical Characterization: Detailed documentation of clinical features in donors, enabling correlation of clinical symptoms with neuropathological findings.
Banner Sun Health researchers have made significant contributions to understanding TDP-43 proteinopathy in neurodegenerative diseases[8]:
The biomarker program at Banner Sun Health focuses on[5:1]:
Fluid Biomarkers: Development and validation of CSF and blood biomarkers for neurodegenerative diseases, including:
Imaging Biomarkers: Collaboration with imaging centers to validate PET and MRI biomarkers.
Clinical Biomarkers: Development of clinical measures and穿戴设备 for monitoring disease progression.
Banner Sun Health is a founding member of the Arizona Alzheimer's Consortium, a statewide collaboration of leading research institutions working to find effective treatments for Alzheimer's disease[9]. The consortium includes:
The consortium enables:
Shared Resources: Pooling of brain bank resources, clinical data, and scientific expertise across institutions.
Clinical Trials: Coordinated clinical trial programs enabling rapid recruitment and diverse participant populations.
Training Programs: Joint training initiatives for the next generation of neurodegeneration researchers.
Data Sharing: Integrated data platforms enabling collaborative analyses.
The Arizona Alzheimer's Consortium has been instrumental in:
Banner Sun Health conducts clinical trials testing novel therapeutic agents for neurodegenerative diseases[3:2]:
Alzheimer's Disease Trials: Testing disease-modifying therapies targeting amyloid-beta, tau, and other therapeutic targets. The institute participates in Phase I-III trials of novel compounds.
Parkinson's Disease Trials: Clinical trials for Parkinson's disease and related disorders, including symptomatic and disease-modifying therapies.
Prevention Trials: Studies in cognitively normal individuals at risk for Alzheimer's disease, testing preventive interventions.
Beyond clinical trials, the institute conducts observational studies:
Memory Screening: Free memory screenings for community members concerned about cognitive changes.
Clinical Evaluation: Comprehensive neurological and neuropsychological evaluations for participants in research programs.
Caregiver Support: Resources and support programs for family members caring for research participants.
Banner Sun Health researchers have made significant contributions to neurodegenerative disease research:
Detailed pathological studies of Lewy bodies in Parkinson's disease have characterized:
Research has advanced understanding of:
Pioneering studies have characterized:
Contributions to biomarker field include:
Banner Sun Health offers training opportunities for:
Postdoctoral Fellows: Research training in neurodegeneration for PhD graduates
Medical Students: Research rotations for medical students interested in neurology
Residents and Fellows: Clinical training in neurodegenerative diseases
Public Lectures: Regular presentations on brain health and neurodegenerative diseases
Caregiver Training: Programs supporting family caregivers
Professional Education: Continuing education for healthcare providers
Banner Sun Health maintains active collaborations[10]:
Plans include:
Strategic priorities include:
The institute plans to:
Initiatives include:
Banner Sun Health maintains state-of-the-art research facilities:
Neuropathology Laboratory: Fully equipped laboratory for brain tissue processing, including:
Biomarker Laboratory: CLIA-certified laboratory for biomarker analysis:
Clinical Research Unit: Facilities for conducting clinical trials:
The institute maintains comprehensive data resources:
Beyond brain tissue, the institute maintains:
The brain donation program relies on community engagement:
Community Outreach: Staff members regularly present to community groups, senior centers, and healthcare providers to recruit potential donors.
Physician Referrals: Healthcare providers throughout the Phoenix metropolitan area refer patients to the brain donation program.
Longitudinal Follow-up: Participants are followed throughout life, with regular assessments documenting cognitive and functional status.
Community Lectures: Regular presentations on brain health, memory concerns, and advances in neurodegenerative disease research.
Memory Screenings: Free memory screenings available to community members.
Caregiver Support: Support groups and educational programs for family caregivers of individuals with neurodegenerative diseases.
Donor Families: Support for families who have donated loved ones' brains to research.
Community Advisory Board: Community members provide input on research priorities and outreach efforts.
Banner Sun Health research is funded by multiple federal sources[10:1]:
The institute maintains:
The Banner Sun Health Brain Bank has enabled:
Scientific Goals:
Operational Goals:
Educational Goals:
Banner Sun Health envisions:
Researchers interested in obtaining tissue should contact the brain bank office. Applications are reviewed by the scientific advisory committee. Information about application procedures and fees is available on the Banner Health website.
Individuals interested in the brain donation program can contact the institute directly. Program staff will provide information about participation requirements, the consent process, and what to expect.
Healthcare providers can refer patients to the brain donation program or contact the institute regarding clinical trials enrollment.
Address: Banner Sun Health Research Institute, Sun City, Arizona
Phone: Contact through Banner Health main number
Website: https://www.bannerhealth.com/research/
Clinical Trials: https://www.bannerhealth.com/services/research/clinical-trials/